Y. D. de Beer

Ultra-performance liquid chromatography for quantification of amphotericin B plasma concentrations after use of liposomal amphotericin B.

I. Spriet, R. Aarnoutse, J. Maertens, 2020, The Journal of antimicrobial chemotherapy.

Therapeutic drug monitoring of everolimus using the dried blood spot method in combination with liquid chromatography-mass spectrometry.

L. Stolk, G. D. de Jong, C. Neef, 2009, Journal of pharmaceutical and biomedical analysis.

Development and validation of an analytical method using UPLC–MS/MS to quantify everolimus in dried blood spots in the oncology setting

V. Tjan-Heijnen, F. de Vries, L. Stolk, 2018, Journal of pharmaceutical and biomedical analysis.

Clinical validation study of dried blood spot for determining everolimus concentration in patients with cancer

C. V. van Herpen, N. V. van Erp, R. Brüggemann, 2017, European Journal of Clinical Pharmacology.

Development and validation of an HPLC-MS/MS method to simultaneously quantify brigatinib, lorlatinib, pralsetinib and selpercatinib in human K2-EDTA plasma.

V. Tjan-Heijnen, L. Stolk, A. van Veelen, 2023, Biomedical chromatography : BMC.

Fixed Dosing of Liposomal Amphotericin B in Morbidly Obese Individuals

J. Adler-Moore, C. Knibbe, D. Burger, 2019, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.